Next Science Limited is a medical technology company that focuses on eradicating health issues caused by biofilms. Their products, developed using their Xbio Technology platform, include antimicrobial gels and solutions designed to reduce surgical site and post-surgical infections. They have partnerships with respected institutions such as the Mayo Clinic and the University of Florida Department of Otolaryngology. Founded in 2012 and headquartered in Australia, Next Science Limited also has operations in the United States.
Next Science Limited's ticker is NXS
The company's shares trade on the ASX stock exchange
They are based in Chatswood, Australia
There are 11-50 employees working at Next Science Limited
It is https://www.nextscience.com/
Next Science Limited is in the Healthcare sector
Next Science Limited is in the Biotechnology industry
The following five companies are Next Science Limited's industry peers:
- PhaseBio Pharmaceuticals, Inc.